|
π¬
|
Childhood constipation: longitudinal follow-up beyond puberty.
R. van Ginkel,
J. Reitsma,
H. BuΜller,
M. V. van Wijk,
J. Taminiau,
M. Benninga
|
8 |
2003 |
8
π¬
|
|
π¬
|
Efficacy of Proton-Pump Inhibitors in Children With Gastroesophageal Reflux Disease: A Systematic Review
R. J. van der Pol,
M. Smits,
M. V. van Wijk,
T. Omari,
M. Tabbers,
M. Benninga
|
7 |
2011 |
7
π¬
|
|
π¬
|
Long-Term Prognosis for Childhood Constipation: Clinical Outcomes in Adulthood
M. Bongers,
M. V. van Wijk,
J. Reitsma,
M. Benninga
|
7 |
2010 |
7
π¬
|
|
π
|
Rectal Fecal Impaction Treatment in Childhood Constipation: Enemas Versus High Doses Oral PEG
7 auth.
N. Bekkali,
M. M. van den Berg,
M. Dijkgraaf,
M. V. van Wijk,
M. Bongers,
O. Liem,
...
M. Benninga
|
7 |
2009 |
7
π
|
|
π¦
|
Effect of body position changes on postprandial gastroesophageal reflux and gastric emptying in the healthy premature neonate.
9 auth.
M. V. van Wijk,
M. Benninga,
J. Dent,
R. Lontis,
L. Goodchild,
L. McCall,
...
R. Haslam,
G. Davidson,
T. Omari
|
7 |
2007 |
7
π¦
|
|
π¦
|
Role of the Multichannel Intraluminal Impedance Technique in Infants and Children
M. V. van Wijk,
M. Benninga,
T. Omari
|
6 |
2009 |
6
π¦
|
|
π
|
Interobserver and intraobserver variability in pH-impedance analysis between 10 experts and automated analysis.
11 auth.
C. Loots,
M. V. van Wijk,
K. Blondeau,
K. Dalby,
L. Peeters,
R. Rosen,
...
S. Salvatore,
T. Wenzl,
Y. Vandenplas,
M. Benninga,
T. Omari
|
6 |
2012 |
6
π
|
|
π¬
|
Gastroesophageal reflux, esophageal function, gastric emptying, and the relationship to dysphagia before and after antireflux surgery in children.
C. Loots,
Maud Y. A. van Herwaarden,
M. Benninga,
David C VanderZee,
M. V. van Wijk,
T. Omari
|
5 |
2013 |
5
π¬
|
|
π’
|
Pediatric Achalasia in the Netherlands: Incidence, Clinical Course, and Quality of Life.
16 auth.
M. Smits,
M. van Lennep,
Remy Vrijlandt,
M. Benninga,
J. Oors,
R. Houwen,
F. Kokke,
D. van der Zee,
Johanne Escher,
A. M. van den Neucker,
...
T. D. de Meij,
F. Bodewes,
J. Schweizer,
G. Damen,
O. Busch,
M. V. van Wijk
|
5 |
2016 |
5
π’
|
|
π¬
|
Efficacy and safety of histamine-2 receptor antagonists.
R. J. van der Pol,
M. Langendam,
M. Benninga,
M. V. van Wijk,
M. Tabbers
|
5 |
2014 |
5
π¬
|
